Amylyx Pharmaceuticals Secures $5,000,000 Series A Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d59a98b5-5830-432e-8460-bc154571f6d0 - Date
8/24/2016 - Company Name
Amylyx Pharmaceuticals - Mailing Address
210 Broadway Cambridge, MA 02139 USA - Company Description
Amylyx is an IND-enabling stage biopharmaceutical company dedicated to providing innovative, disease-modifying solutions for neurodegenerative diseases. We have a highly creative and motivated team focused on streamlined clinical development and drug discovery. - Website
http://www.amylyx.com - Transaction Type
Venture Equity - Transaction Amount
$5,000,000 - Transaction Round
Series A - Proceeds Purposes
Our investment in Amylyx is aligned with the Fund’s goals of driving medical advancement for this terrible disease. - M&A Terms
- Venture Investor
Morningside Group - Venture Investor
Investor
